Information on the handling of applications for marketing authorisation of medicinal products through the national procedure, MRP or DCP, marketing authorisation renewal and applications for marketing authorisation variation through the national procedure, MRP or DCP, and applications for permission of parallel import of a medicinal product, pursuant to Section 32, paragraph 1 of the Act on Pharmaceuticals, is available at http://www.sukl.cz/leciva/zmena-ve-vyrizovani-zadosti-o-registraci-prodlouzeni .
Home
/
Medicines
/
Marketing authorisation of pharmaceuticals
/
Details of marketing authorisation
/
Questions and answers on the amended Act on...
/
General question
/
How does the amended Act on Pharmaceuticals...